4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001442002-16-000001
$ELTPCIK 0001053369operating
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:17 PM ET
Size
7.9 KB
Accession
0001442002-16-000001
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Other
common
2015-10-30+113,954→ 113,954 total(indirect: See Footnote)
Holdings
- 2,700,000(indirect: By IRA)
Common Stock
- 19,072,514
Common Stock
Mikah Pharma, LLC
10% Owner
Transactions
- Other
common
2015-10-30+113,954→ 113,954 total(indirect: See Footnote)
Holdings
- 19,072,514
Common Stock
- 2,700,000(indirect: By IRA)
Common Stock
Footnotes (4)
- [F1]Milestone payment from company pursuant to a Strategic Alliance Agreement with Entity.
- [F2]Shares eventually transferred from Entity in which Mikah Pharma LLC has a beneficial interest to Mikah Pharma LLC.
- [F3]The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.
- [F4]The securities are held by Nasrat Hakim .
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:17 PM ET
- Size
- 7.9 KB